Abstract
Background Indoor Residual Spraying (IRS) of insecticides is a key method to reduce transmission by Triatoma infestans, vector of Chagas disease in a large part of South America. However, the successes of IRS in the Gran Chaco region straddling Bolivia, Argentina and Paraguay, have not equalled those in other Southern Cone countries.
Aims This study evaluated routine IRS practises and insecticide quality control in a typical endemic community in the Bolivian Chaco.
Methods Alpha-cypermethrin active ingredient (a.i.) concentrations captured onto filter papers fitted to sprayed wall surfaces, and in prepared spray tank solutions, were measured using an adapted Insecticide Quantification Kit (IQK™). The results were analysed by negative binomial GLM regression in relation to the time (minutes) spray teams spent treating houses, spray rates (surface area to spray [m2/minute]), householder compliance to empty houses for IRS delivery, and the visual presence/absence of filter papers. The IQK™ assays developed for these samples were validated against HPLC quantification methods. Results: Substantial variations in the delivered a.i. concentrations were observed; only 10.4% (50/480) of filter papers, and 8.8% (5/57) of houses received the target concentration. The delivered concentrations were not related to those in the matched spray tank solutions. The sedimentation of a.i. in the surface solution of prepared spray tanks was rapid, resulting in a 29% loss of a.i. content within 5 minutes, and 48.5% after 15 minutes. The delivered concentrations were positively associated with the time spent spraying the house, and inversely related to the spray rate, but showed weak correlations in both cases. The influence of householder compliance on spray rates were significant, though associated differences in delivered concentrations were not detected. No differences were observed in spray rates between houses fitted with filter papers and houses without.
Conclusions Suboptimal delivery of IRS is partially attributed to the insecticide physical characteristics, and the need for revision of insecticide delivery methods, which includes training of IRS teams and community education to encourage compliance. The IQK™ is a necessary field-friendly tool to improve IRS quality, and to facilitate health worker training and decision making by the Chagas disease vector control managers.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The study was supported by a PhD scholarship to RG from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brasil (CNPq) [204350/2014-0]. OC acknowledges the continued supported of the Wellcome Trust https://wellcome.ac.uk. The funding body played no role in the design of the study, the collection, analysis, interpretation of the data, or in writing the manuscript or decision to submit the paper for publication.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study did not require human or animal ethical approval. The IRS campaigns were carried out by local health workers as routine and as directed by the Chagas Disease Control Program Santa Cruz Administrative Department (Servicio Departamental de Salud SEDES). Permission to accompany the IRS health workers to record their practices was authorised by SEDES and by health authorities at provincial (Red de Salud Cordillera Santa Cruz) and municipal (Secretary of Human Development Camiri) levels and by the Guarani Indigenous District Office (Kaami Capitania) and by the local community leader steering committee (Itanambikua community). The purpose of the observing researcher presence was fully explained to the householders who gave their verbal consent.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data supporting the conclusions of this article are included within the article. Data are available from the corresponding authors on reasonable request to be used solely within the context of this study, following the ethical agreements, and with permission from the relevant authorities and co-authors.
